{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-23-013894","form_type":"8-K","ticker":"USBC","cik":"0001074828","company_name":"USBC, Inc.","filed_at":"2023-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.133972+00:00","generated_at":"2026-06-08T08:38:07.426768+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Know Labs expands board to 7 with three new directors from IP and diabetes sectors","bullets":["John Cronin, Larry Ellingson, and Timothy Londergan appointed as independent directors effective Nov 3, 2023.","Cronin helped boost Know Labs' patent portfolio from 86 to 246 issued, pending or in-process patents in 12 months.","Ellingson, former Eli Lilly diabetes head, served on Know Labs' advisory board for 4 years prior.","Londergan, CEO of Tangibly, was named IAM 300 World's Leading IP Strategist 2023.","New directors receive annual stock option grants and cash retainer of $10,000–$12,500."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-23-013894","json":"https://secwatch.observer/filing/0001654954-23-013894.json","markdown":"https://secwatch.observer/filing/0001654954-23-013894.md","text":"https://secwatch.observer/filing/0001654954-23-013894.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1074828/000165495423013894/0001654954-23-013894-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1074828/000165495423013894/knwn_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T08:38:07.426768+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"360da1b11f","claim":"John Cronin was appointed as Director at USBC, Inc..","evidence_excerpt":"On November 3, 2023, the Board of Directors (“Board”) of Know Labs, Inc. (the “Company”) appointed Larry K. Ellingson, John Cronin and Timothy M. Londergan, as new non-employee members of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1074828/000165495423013894/0001654954-23-013894-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"3fe302393f","claim":"Larry K. Ellingson was appointed as Director at USBC, Inc..","evidence_excerpt":"On November 3, 2023, the Board of Directors (“Board”) of Know Labs, Inc. (the “Company”) appointed Larry K. Ellingson, John Cronin and Timothy M. Londergan, as new non-employee members of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1074828/000165495423013894/0001654954-23-013894-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"fda257a90b","claim":"Timothy M. Londergan was appointed as Director at USBC, Inc..","evidence_excerpt":"On November 3, 2023, the Board of Directors (“Board”) of Know Labs, Inc. (the “Company”) appointed Larry K. Ellingson, John Cronin and Timothy M. Londergan, as new non-employee members of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1074828/000165495423013894/0001654954-23-013894-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}